Prophylactic mastectomy

被引：26

作者：

Newman, LA ^{[1
]}

Kuerer, HM ^{[1
]}

Hunt, KK ^{[1
]}

Vlastos, G ^{[1
]}

Ames, FC ^{[1
]}

Ross, MI ^{[1
]}

Singletary, SE ^{[1
]}

机构：

[1] Univ Texas, MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA

来源：

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2000年 / 191卷 / 03期

关键词：

D O I：

10.1016/S1072-7515(00)00361-6

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

[No abstract available]

引用

页码：322 / 330

页数：9

共 55 条

[1]

Armes JE, 1999, CANCER RES, V59, P2011

[2]

BLOOM ND, 1980, NEW YORK STATE J MED, V80, P908

[3] CONTRALATERAL BREAST-CANCER - ANNUAL INCIDENCE AND RISK PARAMETERS [J].

BROET, P ;

DELAROCHEFORDIERE, A ;

SCHOLL, SM ;

FOURQUET, A ;

MOSSERI, V ;

DURAND, JC ;

POUILLART, P ;

ASSELAIN, B .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1578-1583

[4] The effect of raloxifene on risk of breast cancer in postmenopausal women - Results from the MORE randomized trial [J].

Cummings, SR ;

Eckert, S ;

Krueger, KA ;

Grady, D ;

Powles, TJ ;

Cauley, JA ;

Norton, L ;

Nickelsen, T ;

Bjarnason, NH ;

Morrow, M ;

Lippman, ME ;

Black, D ;

Glusman, JE ;

Costa, A ;

Jordan, VC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (23) :2189-2197

[5]

ELDAR S, 1984, AM J SURG, V148, P692, DOI 10.1016/0002-9610(84)90352-0

[6] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[7] RISKS OF CANCER IN BRCA1-MUTATION CARRIERS [J].

FORD, D ;

EASTON, DF ;

BISHOP, DT ;

NAROD, SA ;

GOLDGAR, DE ;

HAITES, N ;

MILNER, B ;

ALLAN, L ;

PONDER, BAJ ;

PETO, J ;

SMITH, S ;

STRATTON, M ;

LENOIR, GM ;

FEUNTEUN, J ;

LYNCH, H ;

ARASON, A ;

BARKARDOTTIR, R ;

EGILSSON, V ;

BLACK, DM ;

KELSELL, D ;

SPURR, N ;

DEVILEE, P ;

CORNELISSE, CJ ;

VARSEN, H ;

BIRCH, JM ;

SKOLNICK, M ;

SANTIBANEZKOREF, MS ;

TEARE, D ;

STEEL, M ;

PORTER, D ;

COHEN, BB ;

CAROTHERS, A ;

SMYTH, E ;

WEBER, B ;

NEWBOLD, B ;

BOEHNKE, M ;

COLLINS, FS ;

CANNONALBRIGHT, LA ;

GOLDGAR, D .

LANCET, 1994, 343 (8899) :692-695

[8] Sequence analysis of BRCA1 and BRCA2:: Correlation of mutations with family history and ovarian cancer risk [J].

Frank, TS ;

Manley, SA ;

Olopade, OI ;

Cummings, S ;

Garber, JE ;

Bernhardt, B ;

Antman, K ;

Russo, D ;

Wood, ME ;

Mullineau, L ;

Isaacs, C ;

Peshkin, B ;

Buys, S ;

Venne, V ;

Rowley, PT ;

Loader, S ;

Offit, K ;

Robson, M ;

Hampel, H ;

Brener, D ;

Winer, EP ;

Clark, S ;

Weber, B ;

Strong, LC ;

Rieger, P ;

McClure, M ;

Ward, BE ;

Shattuck-Eidens, D ;

Oliphant, A ;

Skolnick, MH ;

Thomas, A .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (07) :2417-2425

[9] PROJECTING INDIVIDUALIZED PROBABILITIES OF DEVELOPING BREAST-CANCER FOR WHITE FEMALES WHO ARE BEING EXAMINED ANNUALLY [J].

GAIL, MH ;

BRINTON, LA ;

BYAR, DP ;

CORLE, DK ;

GREEN, SB ;

SCHAIRER, C ;

MULVIHILL, JJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (24) :1879-1886

[10] Survival from contralateral breast cancer [J].

Gajalakshmi, CK ;

Shanta, V ;

Hakama, M .

BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) :115-122

← 1 2 3 4 5 6 →